These results support the hypothesis that TUDCA improves the defective hepatic autophagy, activation of ER stress, and impaired insulin signaling induced by obesity, thereby offering novel opportunities for the treatment of obesity. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.